Nanosphere, Inc. is a nanotechnology-based healthcare company, offering proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify diagnostic testing. Nanosphere was founded in the year 2000 based upon nanotechnology discoveries at Northwestern University in Evanston, Illinois by Dr. Robert Letsinger and Dr. Chad Mirkin.
GeneFluidics, Inc. develops electrochemical sensor platform for molecular analysis. Its solutions perform bioassays with sensitivity to picogram/ml concentrations for immunoassays and femtomolar concentrations for genetic assays.
Fluidigm Corporation is a leading innovator in the single-cell biology (genomics and proteomics) market. We simplify the complex quest to understand and apply biology by developing and manufacturing analytical and preparatory systems for single-cell biology and production genomics markets that significantly streamline experimental workflows, increase throughput, and reduce costs, while providing excellent data quality.
U.S. Genomics has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company's innovative technologies which include proprietary technologies for extraction of high grade DNA from complex samples, tagging, microfluidics and genomic mapping, address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring.
We assemble structures and chemistries at all length scales on flat, curved, smooth, and uneven surfaces made of a broad range of materials, including metals, polymers, oxides, and ceramics. We assemble these structures and chemistries over small and large areas, and integrate these into practical two- and three-dimensional systems and devices.
Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.
BioProcessors Corp. is a pioneer in innovating high-throughput biopharmaceutical
process development technology and is the leader in providing biopharmaceutical
upstream process development applications for the biotechnology and pharmaceutical
We were the first to identify the combination of microfluidics and light responsive polymers being developed by Molecular Vision in London as having the potential of completely revolutionising the Point of Care (PoC) diagnostics market. This lab on a chip diagnostic platform has the potential to produce simple to use compact, low cost, hand held device where the analytical capabilities of a number of standard pieces of laboratory equipment can be duplicated.